Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.44 |
| ▸ | PNMT | P11086 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8539519 | 0.85 | GABRA1 (0.50) | TAAR1GABRA1GABRB2PNMTSLC6A2 | |
| SCHEMBL2563917 | 0.84 | PNMT (0.62) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL10249345 | 0.84 | PNMT (0.62) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL29968153 | 0.84 | PNMT (0.62) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL12136140 | 0.84 | PNMT (0.62) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL24884040 | 0.84 | TAAR1 (0.46) | TAAR1IDO1ACHEALDH1A1CYP2D6 | |
| SCHEMBL8257853 | 0.83 | TAAR1 (0.48) | TAAR1IDO1ACHEALDH1A1CYP2D6 | |
| SCHEMBL19232414 | 0.83 | TAAR1 (0.48) | TAAR1IDO1ACHEALDH1A1CYP2D6 | |
| SCHEMBL14997302 | 0.83 | TAAR1 (0.48) | TAAR1IDO1ACHEALDH1A1CYP2D6 | |
| SCHEMBL22579846 | 0.83 | TAAR1 (0.48) | TAAR1IDO1ACHEALDH1A1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4324810-A1 | PROCESS FOR THE SYNTHESIS OF MIBT | Vinati Organics Limited (IN) | 2024-02-21 | — | — | EP | claimed |
| EP-3089956-B1 | PROCESS | GIVAUDAN SA (CH) | 2019-08-07 | — | — | EP | claimed |
| EP-4046986-B1 | METHOD FOR PRODUCING 2,4-DIALKYLBENZALDEHYDE | MITSUBISHI GAS CHEMICAL CO (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-12145903-B2 | Method for producing 2,4-dialkylbenzaldehyde | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-11-19 | — | — | US | disclosed |
| US-20240279146-A1 | ALICYCLIC ALCOHOL, ALICYCLIC ALCOHOL COMPOSITION, AND PERFUME COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-08-22 | — | — | US | disclosed |
| US-12024487-B2 | Method for producing m-dialkylbenzaldehyde | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-07-02 | — | — | US | disclosed |
| CN-114514217-B | Process for producing 2, 4-dialkylbenzaldehyde | 三菱瓦斯化学株式会社 | 2024-06-11 | — | — | CN | disclosed |
| CN-114127039-B | Process for producing m-dialkylbenzaldehyde | 三菱瓦斯化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| US-11987545-B2 | — | — | 2024-05-21 | — | — | US | disclosed |
| EP-3218341-B1 | PHENYL BASED COMPOUNDS SUBSTITUTED WITH ALDEHYDE MOIETIES AND THEIR USE IN PERFUMERY | GIVAUDAN SA (CH) | 2024-05-01 | — | — | EP | disclosed |
| US-20240132434-A1 | METHOD FOR PRODUCING 2,4-DIALKYLBENZALDEHYDE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-04-25 | — | — | US | disclosed |
| WO-2003063771-A2 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS | PHARMASSET LTD. (BB) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003051298-A2 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003051306-A2 | N4-ACYLCYTOSINE-1,3-DIOXOLANE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| US-6489527-B1 | Process for improving purity of para-xylene product | OU JOHN DI-YI (US) | 2002-12-03 | — | — | US | disclosed |
| EP-0646104-B1 | PROCESS FOR IMPROVING PURITY OF $i(PARA)-XYLENE PRODUCT | EXXON CHEMICAL PATENTS INC (US) | 1996-10-09 | — | — | EP | disclosed |
| EP-0646104-A1 | PROCESS FOR IMPROVING PURITY OF -i(PARA)-XYLENE PRODUCT. | EXXON CHEMICAL PATENTS INC (US) | 1995-04-05 | — | — | EP | disclosed |
| WO-1993024432-A1 | PROCESS FOR IMPROVING PURITY OF PARA-XYLENE PRODUCT | EXXON CHEMICAL PATENTS INC. (US) | 1993-12-09 | — | — | WO | disclosed |
| US-3987150-A | AMMONIUM CHLORIDE AND NITROGEN DIOXIDE | ALLIED CHEMICAL CORPORATION (US) | 1976-10-19 | — | — | US | disclosed |
| US-3941786-A | Process for the production of 4-hydroxy-6-hydroxymethylpyrimidine | LONZA LTD. (CH) | 1976-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240132434-A1 | METHOD FOR PRODUCING 2,4-DIALKYLBENZALDEHYDE | CBR1, AFF1, ALKBH1 | TAAR1 752/4885IDO1 611/4885ACHE 4508/4885 |
| US-20240279146-A1 | ALICYCLIC ALCOHOL, ALICYCLIC ALCOHOL COMPOSITION, AND PERFUME COMPOSITION | ADH1A, ADH1C, ADH5 | TAAR1 633/4885IDO1 808/4885ACHE 1999/4885 |
| US-11987545-B2 | — | ME1, BDKRB1, DIMT1 | TAAR1 130/4885IDO1 413/4885ACHE 4034/4885 |
| US-12145903-B2 | Method for producing 2,4-dialkylbenzaldehyde | CBR1, AFF1, ALKBH1 | TAAR1 752/4885IDO1 611/4885ACHE 4508/4885 |
| US-12024487-B2 | Method for producing m-dialkylbenzaldehyde | ME1, DIMT1, ME3 | TAAR1 185/4885IDO1 642/4885ACHE 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.